pharmaphorum
DECEMBER 9, 2020
Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that there are still uncertainties about whether the shot can stop the disease from spreading. of participants. of participants.
pharmaphorum
SEPTEMBER 10, 2020
The programme is still in the early stages of development, but if it works in trials would provide another approach to prevent transmission of SARS-CoV-2, the virus that causes COVID-19, alongside vaccines and prophylactic antibodies. subtilis spores engineered to present SARS-CoV-2 antigens to the mucosal immune system.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 20, 2022
Health Canada has granted expanded authorisation for Novavax ’s Covid-19 vaccine (Recombinant protein, Adjuvanted) [Nuvaxovid; NVX-CoV2373] as a homologous booster for usage in adults aged 18 and above. The vaccine is indicated for active immunisation to prevent the disease.
PharmaShots
FEBRUARY 28, 2023
The signs and symptoms of a potential vaccine injury can vary. Other adverse reactions that could be attributed to a vaccine injury include neurological disorders such as seizures, autoimmune diseases, and allergic reactions. Read on to learn more about vaccine injuries and their symptoms.
European Pharmaceutical Review
DECEMBER 19, 2022
Treatment and care of patients with high-risk NMIBC, including those with CIS often involves removing the tumour and the use of the BCG vaccine to reduce the risk that the cancer will recur. The FDA stated that individuals who are immunosuppressed, or immune-deficient should not come into contact with Adstiladrin.
The Infectious Pharmacist
AUGUST 24, 2021
Today I’ll answer some “reader mailbag” questions about COVID-19 vaccine booster doses, breakthrough infections, Delta, and how they all connect. be offering COVID-19 vaccine booster doses? But supply is not the primary issue behind our suboptimal vaccination rates. What about checking for antibodies in vaccinated patients?
The Infectious Pharmacist
AUGUST 21, 2021
Pfizer vs. Moderna and a note on vaccine dosing and timing. You probably have read news reports about a preprint article stating that the Moderna vaccine appeared more effective than the Pfizer vaccine, at least several months after vaccination. Should I stick with the same mRNA vaccine I got for the first two doses?
Expert insights. Personalized for you.
110 
Let's personalize your content